BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $1,337,661 (100.0% shares, 0.0% debt)

Holdings (7)

MNST MONSTER BEVERAGE CORP NEW 40.0%

Value ($000) $534,937 Shares 9,312,976 Est. Cost $36.99 Unrealized +53.7%

STAA STAAR SURGICAL CO 34.5%

Value ($000) $461,727 Shares 8,783,082 Est. Cost $9.40 Unrealized +548.1%

AXON AXON ENTERPRISE INC 11.1%

Value ($000) $148,303 Shares 760,062 Est. Cost $27.50 Unrealized +653.4%

IWM ISHARES TR 9.7%

Value ($000) $129,216 Shares 690,000 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 3.7%

Value ($000) $49,259 Shares 34,935,485 Est. Cost $1.04 Unrealized +32.3%

— ONCOCYTE CORP 0.9%

Value ($000) $11,542 Shares 50,181,335 Est. Cost $1.40 Unrealized —

— AGEX THERAPEUTICS INC 0.2%

Value ($000) $2,677 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	9,312,976	$534,937	40.0%	$36.99	+53.7%	COM	61174X109
STAA	STAAR SURGICAL CO	8,783,082	$461,727	34.5%	$9.40	+548.1%	COM PAR $0.01	852312305
AXON	AXON ENTERPRISE INC	760,062	$148,303	11.1%	$27.50	+653.4%	COM	05464C101
IWM	ISHARES TR	690,000	$129,216	9.7%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS IN	34,935,485	$49,259	3.7%	$1.04	+32.3%	COM	53566P109
—	ONCOCYTE CORP	50,181,335	$11,542	0.9%	$1.40	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$2,677	0.2%	$2.99	—	COM	00848H108